Self-assembling and pH-responsive protein nanoparticle as potential platform for targeted tumor therapy
A Corrigendum on
Self-assembling and pH-responsive protein nanoparticle as potential platform for targeted tumor therapy
by Xu Z, Zhang X, Dong W, lv H, Zuo L, Zhu L, Wang R and Ma X (2023). Front. Mol. Biosci. 10:1172100. doi: 10.3389/fmolb.2023.1172100
In the published article, there was an error in the Funding statement. The funding information was missing. The correct Funding statement appears below.
“This work supported by Henan Province key research and promotion special project: 212102110374. Key scientific research project of Henan Province:21B230004, 20A230005, Starting Research Fund from the Henan University of Animal Husbandry and Economy: 2019HNUAHEDF004, National Natural Science Foundation of China (NSFC): 31902274 and National Natural Science Foundation of China: 32072906.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Funding
This work supported by Henan Province key research and promotion special project: 212102110374. Key scientific research project of Henan Province:21B230004, 20A230005, Starting Research Fund from the Henan University of Animal Husbandry and Economy: 2019HNUAHEDF004, National Natural Science Foundation of China (NSFC): 31902274 and National Natural Science Foundation of China: 32072906.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: trichosanthin, self-assembly, pH-Responsive, protein nanoparticle, tumor targeting
Citation: Xu Z, Zhang X, Dong W, lv H, Zuo L, Zhu L, Wang R and Ma X (2023) Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy. Front. Mol. Biosci. 10:1232803. doi: 10.3389/fmolb.2023.1232803
Received: 01 June 2023; Accepted: 02 June 2023;
Published: 22 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Xu, Zhang, Dong, lv, Zuo, Zhu, Wang and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhikun Xu, xuzhikun@hnuahe.edu.cn